Researchers find bioreactor supports whole lung regeneration
Stephen FellerWASHINGTON, May 4 (UPI) -- Researchers at Yale University devised a mechanical system that can support the growth of whole lungs from patient cells to use in transplants. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 4, 2016 Category: Consumer Health News Source Type: news

HeartWare dives on big Q1 sales, earnings misses
Shares prices for HeartWare International (NSDQ:HTWR) plunged this morning after the implantable heart pump maker posted 1st-quarter earnings that badly missed expectations on Wall Street. Framingham, Mass.-based HeartWare reported that losses widened 20.1% to -$17.5 million, or -$1 per share, on a -21.3% revenue slide to $55.1 million. Adjusted to exclude 1-time items, losses per share were -95¢, -16¢ off the forecast on The Street, where analysts were looking for sales of $59.9 million. “In the 1st quarter, our international revenue performance was impacted by competitive dynamics in Germany, as...
Source: Mass Device - May 4, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiac Assist Devices MassDevice Earnings Roundup Wall Street Beat HeartWare International Inc. Source Type: news

Double lung transplant recipient gives back to group that fought on his behalf
A man who successfully received a double lung transplant three years ago is giving back to the Lung Association of Nova Scotia. (Source: CBC | Health)
Source: CBC | Health - May 3, 2016 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news

New research from Yale and MIT describes bioreactor to support whole lung regeneration
(Mary Ann Liebert, Inc./Genetic Engineering News) An innovative mechanical system that mimics the ventilation and blood flow in the chest cavity, housed in a specialized, sterile bioreactor, can support the growth of engineered whole lungs at human scale. Researchers designed this biomimetic environment to advance toward clinical application of whole lung regeneration for transplant using a patient's own cells, as described in BioResearch Open Access. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2016 Category: Global & Universal Source Type: news

Older Lung Donors Raise Mortality Risk Only SlightlyOlder Lung Donors Raise Mortality Risk Only Slightly
Pushing the maximum recommended donor age for lung transplants from 55 to 64 years greatly expands the donor pool, with only a slight increase in recipient mortality. However, more research is needed. Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 2, 2016 Category: Transplant Surgery Tags: Transplantation News Source Type: news

Teacher Runs 5K Months After Undergoing Double Lung Transplant
BOSTON (CBS) — For 32-year-old Eamonn Kelly, crossing the finish line during a 5K race this weekend is more than just a dream come true; it’s really a new start at life. “I’m going to set my goal and do it,” he told WBZ. Kelly was born with cystic fibrosis, a genetic disease that affects the lungs. The older he got, the more his life began to deteriorate, he said. “Before the transplant, I was on oxygen 24-7,” Kelly says. “I had to carry a tank with me and it made life difficult for me.” Refusing to accept life this way, Kelly underwent a double lung transplant at Massa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 1, 2016 Category: Consumer Health News Authors: mouellette2015 Tags: Health Local News Seen On WBZ-TV Syndicated Local Watch Listen cystic fibrosis Kim Tunnicliffe Paul Burton Transplant Source Type: news

Cancer Screening Tests All Women Should Know About
By Stacy Simon Along with giving Mother's Day gifts and sending greetings this year, encourage the moms in your life to get up to date on cancer screening tests. Screening tests look for cancer before a person has any signs or symptoms. Regular screenings can catch some cancers early, when they’re small, have not spread, and are easier to treat. With cervical and colon cancers, these tests can even prevent cancer from developing in the first place. Sweeten the deal by offering to help your mom schedule her screening, drive her to and from appointments, and keep her company in the waiting room. These are the American ...
Source: American Cancer Society :: News and Features - April 29, 2016 Category: Cancer & Oncology Tags: Prevention/Early Detection Breast Cancer Cervical Cancer Endometrial Cancer Colon/Rectum Cancer Lung Cancer - Non-Small Cell Source Type: news

Should Patients in Their 70s Get Lung Transplants?Should Patients in Their 70s Get Lung Transplants?
As the age of lung transplant patients increases, the age of recipients and the stewardship of organs have become controversial. Experts debated these issues at a heart and lung transplant meeting. Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - April 28, 2016 Category: Transplant Surgery Tags: Transplantation News Source Type: news

Left Ventricular Assist Results Lead Transplant MeetingLeft Ventricular Assist Results Lead Transplant Meeting
First-year performance results for the small implantable left ventricular assist device will be presented at the International Society for Heart and Lung Transplantation Scientific Sessions. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 20, 2016 Category: Consumer Health News Tags: Transplantation News Source Type: news

International Society for Heart and Lung Transplantation (ISHLT) 2016 Scientific SessionsInternational Society for Heart and Lung Transplantation (ISHLT) 2016 Scientific Sessions
Read clinically focused news coverage of key developments from ISHLT 2016. Medscape Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 18, 2016 Category: Consumer Health News Tags: Conference Coverage Source Type: news

Health Highlights: April 18, 2016
NFL Concussion Settlement Upheld by Appeals Court Pancreas Cell Transplants Reduce Type 1 Diabetes Patients' Risk of Complications: Study Teen Ordered to Undergo Chemotherapy Says New Mass Found in Lungs Large Health Coverage Gains for Minorities Under Affordable Care Act (Source: U.S. News - Health)
Source: U.S. News - Health - April 18, 2016 Category: Consumer Health News Source Type: news

High-volume lung transplant centers have lower costs and readmissions
High-volume lung transplant centers have lower transplantation costs and their patients are less likely to be readmitted within 30 days of leaving the hospital following surgery, according to a new study of more than 3,000 Medicare patients who received lung transplants. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 14, 2016 Category: Science Source Type: news

High-volume lung transplant centers have lower costs and readmissions
(American Thoracic Society) High-volume lung transplant centers have lower transplantation costs and their patients are less likely to be readmitted within 30 days of leaving the hospital following surgery, according to a new study of more than 3,000 Medicare patients who received lung transplants. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 14, 2016 Category: Global & Universal Source Type: news

Kamada starts Alpha-1 Antitrypsin phase 2 clinical trial to prevent lung transplant rejection
Kamada has started a phase 2 clinical trial with its proprietary drug Alpha-1 Antitrypsin (AAT) for preventing rejection in lung transplants, as part of a collaboration with Baxalta. (Source: Drug Development Technology)
Source: Drug Development Technology - April 6, 2016 Category: Pharmaceuticals Source Type: news

Hope for transplant patients: Baboons survive more than two years with pig hearts
Researchers at the National Heart, Lung and Blood Institute in Maryland say the technique, called immunomodulation, is ready to be used in human trials for the first time (stock image pictured). (Source: the Mail online | Health)
Source: the Mail online | Health - April 5, 2016 Category: Consumer Health News Source Type: news

FDA Approves Defitelio (defibrotide sodium) for Hepatic Veno-Occlusive Disease Following Hematopoietic Stem-Cell Transplantation
March 30, 2016 -- The U.S. Food and Drug Administration today approved Defitelio (defibrotide sodium) to treat adults and children who develop hepatic veno-occlusive disease (VOD) with additional kidney or lung abnormalities after they receive a... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 30, 2016 Category: Drugs & Pharmacology Source Type: news

Doctors at Stanford Hospital perform rare 'domino' transplant
Stephen FellerSTANFORD, Calif., March 30 (UPI) -- One woman received a heart-lung transplant, and her heart was then given to another woman, in an exceptionally rare surgery performed at Stanford Hospital. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 30, 2016 Category: Consumer Health News Source Type: news

FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
The U.S. Food and Drug Administration today approved Defitelio (defibrotide sodium) to treat adults and children who develop hepatic veno-occlusive disease (VOD) with additional kidney or lung abnormalities after they receive a stem cell transplant from blood or bone marrow called hematopoietic stem cell transplantation (HSCT). This is the first FDA-approved therapy for treatment of severe hepatic VOD, a rare and life-threatening liver condition. (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 30, 2016 Category: American Health Source Type: news

I Am My Mother's Chimera. Chances Are, So Are You.
For years the concept of a "genetic chimera" -- an individual with two genetically distinct cells lines in his/her body -- has sparked the imagination of writers: from Stephen King to Michael Crichton, from CSI to The Office. The idea that an individual could harbor his/her own twin is creepy and intriguing at the same time. Recent advances in DNA sequencing technology have allowed us to probe much deeper into a person's genome, to the point that today scientists believe that chimerism could be far more common than what we originally thought. Chances are, you could be your own twin. But how surprised would you ...
Source: Science - The Huffington Post - March 18, 2016 Category: Science Source Type: news

I Am My Mother's Chimera. Chances Are, So Are You.
For years the concept of a "genetic chimera" -- an individual with two genetically distinct cells lines in his/her body -- has sparked the imagination of writers: from Stephen King to Michael Crichton, from CSI to The Office. The idea that an individual could harbor his/her own twin is creepy and intriguing at the same time. Recent advances in DNA sequencing technology have allowed us to probe much deeper into a person's genome, to the point that today scientists believe that chimerism could be far more common than what we originally thought. Chances are, you could be your own twin. But how surprised would you b...
Source: Science - The Huffington Post - March 18, 2016 Category: Science Source Type: news

Innovative lung transplant procedure takes place at Mater
Development means donor organs previously classed unsuitable now safe for recipients (Source: The Irish Times - Health)
Source: The Irish Times - Health - March 16, 2016 Category: Consumer Health News Source Type: news

Innovative new lung transplant procedure takes place at Mater
Donor organs previously classed as unsuitable now safe for recipients (Source: The Irish Times - Health)
Source: The Irish Times - Health - March 16, 2016 Category: Consumer Health News Source Type: news

CardiacAssist wins 510(k) for TandemLung
CardiacAssist said today it won FDA 510(k) clearance for its TandemLung oxygenator designed to operate as an artificial lung by infusing oxygen and removing carbon dioxide from the blood. The Pittsburgh, Penn.-based company said the TandemLung is designed so it can be used along with its TandemHeart blood pump, and combined the devices “represent a leap forward in extracorporeal life support technology for patients in need of critical cardiopulmonary care.” “After our original TandemHeart pump was cleared for use with an oxygenator in 2011, our team immediately began working with experts in the field...
Source: Mass Device - March 15, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Clearance Respiratory CardiacAssist Inc. Source Type: news

New Procedure Allows Kidney Transplants From Any Donor
The procedure, reported in The New England Journal of Medicine, involves a reboot of a patient’s immune system and could also work for lung and liver transplants. (Source: NYT Health)
Source: NYT Health - March 10, 2016 Category: Consumer Health News Authors: GINA KOLATA Tags: Segev, Dorry Transplants New England Journal of Medicine Kidneys Organ Donation Immune System Source Type: news

TransMedics launches pivotal trial for OCS liver transplant system
TransMedics said today that it launched a pivotal study of its OCS Liver device, which is designed to keep donated human liver warm and perfused until transplantation. Andover, Mass.-based TransMedics said the 1st liver transplantation using OCS Liver was performed at Mass. General Hospital by Dr. James Markmann, a lead investigator for the 300-patient OCS Liver Protect trial and chairman of its steering committee. “It is our hope that the ability to preserve a liver in the manner offered by the OCS technology will save lives by making the livers we use function better and by making more organs available for tra...
Source: Mass Device - February 23, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Surgical Organ Transplant Transmedics Inc. Source Type: news

Why walking by a main road is as bad for you as smoking
William Phin, six, from Whitley Bay, north of Newcastle, has obliterative bronchiolitis - which may be triggered by pollution. A lung transplant is the only cure. (Source: the Mail online | Health)
Source: the Mail online | Health - February 23, 2016 Category: Consumer Health News Source Type: news

Artificial lung developer ALung raises $12m
Artificial lung-like device developer ALung Technologies said today it closed a $12 million round of financing to support the continued commercialization of its minimally invasive Hemolung Respiratory Assist System. Pittsburgh-based ALung’s Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small catheter inserted into the jugular or femoral vein. “This new financing reflects continued recognition by the investment community of the potential for our Hemolung technology to revolutionize...
Source: Mass Device - February 22, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Respiratory ALung Technologies Inc. Source Type: news

Anatomy of a transplant: 13 lives, 17 days
Some members of the Pediatric Transplant Center team who performed a record number of transplants in January pose for a picture. It was “lucky 13” for the Boston Children’s Hospital Pediatric Transplant Center this January. Thirteen lives were saved by organ transplantation. Seven kidneys, three hearts, two livers and one pair of lungs were transplanted during the record-breaking month. So what does it take to perform 13 transplants in 17 days? “It takes a team,” says Dr. Heung Bae Kim, director of the Boston Children’s Pediatric Transplant Center. “We are very fortunate to ha...
Source: Thrive, Children's Hospital Boston - February 22, 2016 Category: Pediatrics Authors: Emily Williams Tags: Diseases & Conditions Health & Wellness Our Patients’ Stories double lung transplant Heart Center heart transplant Heart transplant program kidney transplant Liver transplant Lung Transplant Program Pediatric Transplant Center (PTC) Source Type: news

New Cancer Therapy Could Give Hope To 'Incurable' Patients
A new experimental treatment has achieved what chemotherapy and bone marrow transplants have failed to do: put chronic, relapsing blood cancers into remission. What's more, it uses the body's own natural defense system to attack these cancerous growths.  The treatment involves T cells, a type of immune cell that works as your body's own personal S.W.A.T. team to detect, surround, and destroy foreign invaders like bacteria or viruses. Historically, cancerous cells have grown too fast for T cells to mount an effective defense, and they can also trick T cells into thinking that they’re a healthy part of t...
Source: Science - The Huffington Post - February 17, 2016 Category: Science Source Type: news

Mayo Clinic in Arizona Opens Lung Transplant Program
PHOENIX —Mayo Clinic in Arizona  has opened  its lung transplant program and has completed two lung transplants,  a milestone that now completes Mayo’s comprehensive solid organ transplant program, with ability to provide heart, kidney, pancreas, liver and now lung transplants. Mayo received approval by the United Network for Organ Sharing (UNOS) to launch a lung [...] (Source: Mayo Clinic Arizona News)
Source: Mayo Clinic Arizona News - February 17, 2016 Category: Hospital Management Source Type: news

Ensure a Sickness-Free Year With These 6 Habits
Credit One of the greatest blessings anyone can have is living a healthy life. But the abundance of sicknesses and diseases in the world today makes it almost a difficult task. The outbreak of both curable and incurable diseases which are all expensive to deal with is a real problem. But just like the saying goes, prevention is still better than cure. Our habits like they say will either make or mar us. These six habits below are inexpensive and will help you keep all those diseases at bay. 1. Fill up your Styrofoam cup with water more often than not To have a sickness free year, take less of alcohol and much more water. ...
Source: Healthy Living - The Huffington Post - February 16, 2016 Category: Consumer Health News Source Type: news

Toddler makes her way off heart and lung transplant list after 13 surgeries
Zoey Jones, of Tennessee, was born with VACTERL syndrome, a rare condition that left her with an esophagus that was not attached to her trachea, a small intestine unattached to her stomach, and heart and lung abnormalities. (Source: the Mail online | Health)
Source: the Mail online | Health - February 12, 2016 Category: Consumer Health News Source Type: news

UCLA and Stanford researchers pinpoint origin of sighing reflex in the brain
  “You must remember this: a kiss is just a kiss, a sigh is just a sigh.” Contrary to the words immortalized by the piano singer in “Casablanca,” a sigh is far more than a sigh. Heaving an unconscious sigh is a life-sustaining reflex that helps preserve lung function. Now a new study by researchers at UCLA and Stanford has pinpointed two tiny clusters of neurons in the brain stem that are responsible for transforming normal breaths into sighs. Published in the Feb. 8 advance online edition of Nature, the discovery may one day allow physicians to treat patients who cannot breathe deeply on ...
Source: UCLA Newsroom: Health Sciences - February 8, 2016 Category: Universities & Medical Training Source Type: news

2016 Moon Shot for Cancer: Focus on Prevention
It is now 2016, and Americans hope for a brighter, healthier new year. Are Americans healthier today than they were last year or the year before? Will there be fewer people diagnosed with cancer? According to the American Cancer Society, it is projected that in 2016 there will be 1,685,210 new cancer cases and 595,690 deaths due to cancer. This is an increase over previous years. While it is true that the death rate for several cancers has decreased (due mostly to better screening and earlier diagnosis), it is also true that several cancers are on the rise, including cancers of the thyroid, liver, pancreas, kidney, small i...
Source: Healthy Living - The Huffington Post - February 1, 2016 Category: Consumer Health News Source Type: news

Medtech approvals: FDA releases November 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in November 2015: Summary of PMA Originals & Supplements Approved Originals: 3 Supplements: 69 Summary of PMA Originals Under Review Total Under Review: 57 Total Active: 30 Total On Hold: 27 Summary of PMA Supplements Under Review Total Under Review: 583 Total Active: 433 Total On Hold: 150 Summary of All PMA Submissions Originals: 4 Supplements: 75 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 69 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 193.4 FDA Tim...
Source: Mass Device - January 22, 2016 Category: Medical Equipment Authors: MassDevice Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

Mayo Clinic begins construction on new lung transplant center
United Therapeutics CEO Dr. Martine Rothblatt has a personal connection to Mayo Clinic's soon-to-be lung transplant center. Rothblatt, whose company is funding Mayo's three-story center, has a daughter who suffers from pulmonary hypertension, a lung disease that can only be treated with a transplant. She hopes the center, which broke ground on Tuesday and is projected to open in 2017, will help double the number of lung transplants in the U.S., a number that has remained stagnant at 2000 per year… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 19, 2016 Category: Biotechnology Authors: Alexa Epitropoulos Source Type: news

Mesothelioma Center at Loyola Will Grow Under Vigneswaran
Renowned thoracic surgeon Dr. Wickii Vigneswaran left the Loyola University Health System 10 years ago to help start the lung transplant program at nearby University of Chicago Medical Center. He returned to Loyola this year to direct a mesothelioma specialty center, bringing his decade of experience from one of the country's finest research facilities. "I've got the best of both worlds now, and I think patients will really benefit from that," Vigneswaran told Asbestos.com. "We'll continue to collaborate with the best researchers, but now I'll have a broader clinical base at Loyola. It's a win-win situ...
Source: Asbestos and Mesothelioma News - January 18, 2016 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

ALung Technologies raises $10.8 million
Artificial lung-like device developer ALung Technologies raised $10.8 million in a new round of debt financing according to an SEC filing posted this week. The money already raised in the round comes from 63 unnamed investors, according to the SEC filing. Pittsburgh-based ALung’s Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small catheter inserted into the jugular or femoral vein. The company said that the remaining $1.2 million it looks to raise includes notes that are to be issued to Equinox S...
Source: Mass Device - January 13, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blog Source Type: news

Manchester teen with cystic fibrosis writes bucket list before she dies
Chloe Hopkins, 19 of Manchester, has cystic fibrosis and her health is deteriorating. Without a double lung transplant, doctors have said she won't live more than two years (Source: the Mail online | Health)
Source: the Mail online | Health - January 12, 2016 Category: Consumer Health News Source Type: news

In their own words: Six families share the impact of organ donation
This is the season for gratitude and giving, a time to celebrate friends, family, the end of one year and the beginning of a new one. But for a select group, it also is a time to celebrate one of the greatest gifts — the gift of life through organ donation. Mickey was born with a unique combination of congenital heart defects and spent most of his early life at Boston Children’s. He was one day shy of 6 months old when he received his heart transplant, and his family is grateful for every day since. “Mickey has shown us what courage and resiliency look like, and his transplant has taught us the true mean...
Source: Thrive, Children's Hospital Boston - January 5, 2016 Category: Pediatrics Authors: Michelle Higginson Tags: Diseases & Conditions Our Patients’ Stories double lung transplant heart transplant hepatoblastoma kidney transplant Liver transplant multivisceral transplant Pediatric Transplant Center (PTC) Source Type: news

Mapping a way to medication adherence
Eighteen-year-old Maggie Mansfield, a communications major at Boston College, is a two-time double-lung transplant recipient — once, at age 4, due to a condition called pulmonary hypertension in which blood pressure in the arteries of the lungs is abnormally high, and again at age 7, when her body rejected the first transplant. Since then, Maggie has remained relatively healthy due in part to her strict medication regimen. Maggie Mansfield “Timing is the most challenging part of taking my medications,” Maggie says. “As I get older, I get busier. It’s not always easy to stop what I am doing and...
Source: Thrive, Children's Hospital Boston - December 29, 2015 Category: Pediatrics Authors: Emily Williams Tags: Health & Wellness Our Patients’ Stories Teen Health double lung transplant Liver transplant Pediatric Transplant Center (PTC) prescription medication pulmonary hypertension Source Type: news

Lung transplants for children: Exploring the intricacies
Most adult transplant centers require patients to walk a set distance in under six minutes to remain a good candidate for lung transplant. The thought is that if patients cannot meet this minimal threshold, then their chances of being able to rehabilitate after transplant are diminished. In pediatrics, this is also important. But Dawn Freiberger, RN, MSN, Boston Children’s Hospital’s Lung Transplant coordinator, says there are other factors that have to be considered. “The walk test is just one piece of the pie,” says Freiberger. In 2013, Freiberger co-authored a study, Pretransplant...
Source: Mass Device - December 29, 2015 Category: Medical Equipment Authors: MassDevice Tags: Blog Vector Blog Source Type: news

Behind the Headlines' Top Five of Top Fives 2015
In this study, researchers wanted to see why this is and if there could be any human applications.Researchers collected white blood cells from African and Asian elephants. They found that elephants have at least 20 copies of a gene called TP53. TP53 is known to encourage cell "suicide" when DNA is damaged, stopping any potential cancer in its tracks. In contrast, humans are thought to have only a single copy of the TP53 gene.Of course the big question – the elephant in the room, if you will – is how we can boost TP53 activity in humans to stimulate a similar protective effect. The simple answer is: we...
Source: NHS News Feed - December 24, 2015 Category: Consumer Health News Tags: QA articles Medical practice Special reports Source Type: news

Behind the Headlines Top Five of Top Fives 2015
In this study, researchers wanted to see why this is and if there could be any human applications. Researchers collected white blood cells from African and Asian elephants. They found elephants have at least 20 copies of a gene called TP53. TP53 is known to encourage cell "suicide" when DNA is damaged, stopping any potential cancer in its tracks. In contrast, humans are thought to have only a single copy of the TP53 gene. Of course the big question – the elephant in the room, if you will – is how we can boost TP53 activity in humans to stimulate a similar protective effect. The simple answer is: we do...
Source: NHS News Feed - December 24, 2015 Category: Consumer Health News Tags: QA articles Medical practice Special reports Source Type: news

$1 million gift will support UCLA research on advanced lung disease
Philanthropists Michael and Linda Keston have made a gift of $1 million to the Division of Pulmonary and Critical Care Medicine at the David Geffen School of Medicine at UCLA. The donation will support research into advanced lung disease and the UCLA Lung Health Research Initiative, which was launched in November. The initiative is focused on developing new treatments for lung disease and finding a way to prevent the body from rejecting donor organs — a major challenge for people who have received organ transplants. “The Kestons’ contribution will enable our faculty to pursue innovative research that will...
Source: UCLA Newsroom: Health Sciences - December 23, 2015 Category: Universities & Medical Training Source Type: news

FDA approves new orphan drug to treat pulmonary arterial hypertension
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation. (Source: Food and Drug Administration)
Source: Food and Drug Administration - December 22, 2015 Category: American Health Source Type: news

Targeting frailty in pre-lung transplant patients might improve survival rates, patient outcomes
Frailty can affect people of all ages and demographics. Defined simply as 'an increased vulnerability to adverse health outcomes,' frailty can affect a patient's chances of surviving a surgical procedure or needing a nursing home. A new study is among the first to show a definitive connection between frailty and survival after a lung transplant procedure. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 18, 2015 Category: Science Source Type: news

When rejection comes from within
A new cellular structure responsible for previously unexplained rejection of organ transplants has been identified. This discovery could one day revolutionize transplantation practice by modifying risk assessment of rejection in people who receive heart, lung, kidney, or liver transplants. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 16, 2015 Category: Science Source Type: news

Pulmonary Hypertension No Bar to Single-Lung TransplantPulmonary Hypertension No Bar to Single-Lung Transplant
Pulmonary hypertension (PH) does not significantly affect outcome of single-lung transplantation, possibly increasing the number of potential recipients, according to Wisconsin-based researchers. Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - December 15, 2015 Category: Transplant Surgery Tags: Transplantation News Source Type: news

Targeting Frailty in Pre-Lung Transplant Patients Might Improve Survival Rates, Patient Outcomes
Rochester, Minn. — Frailty can affect people of all ages and demographics. Defined simply as “an increased vulnerability to adverse health outcomes,” frailty can affect a patient’s chances of surviving a surgical procedure or needing a nursing home. A new study from physicians at Mayo Clinic in Rochester, Minn., published recently in the Journal of [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - December 15, 2015 Category: Hospital Management Source Type: news